Form 4: CEL-SCI Corp Director Acquires Stock Options
SEC Form 4 Filing
Bruno Baillavoine, a director of CEL-SCI Corp, acquired 64,000 stock options on April 19, 2024.
Summary
- On April 19, 2024, Bruno Baillavoine, a director of CEL-SCI Corp, acquired 64,000 stock options.
- The options have an exercise price of $1.50.
- The options vest in three equal annual installments starting one year after the grant date.
- Following the transaction, Baillavoine directly owns 725,500 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing reflects insider activity, which is closely monitored by investors for signals about a company's prospects. Option grants are a common form of executive compensation in the biotech industry.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/19/2024 | Date of transaction: Bruno Baillavoine acquired 64,000 stock options. |
| 04/23/2024 | Date of signature on the Form 4 filing. |
| 04/18/2034 | Expiration date of the options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.